Several comorbidities are related to chronic GH and/or IGF1 excess, such as cardiovascular, metabolic, osteoarticular and neoplastic complications, which increase the overall mortality of uncontrolled acromegaly [10]. This evidence concerns the gene GH1 and acromegaly.